OTCPK:RHCG.F

Stock Analysis Report

Executive Summary

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia.

Snowflake

Fundamentals

Established dividend payer with moderate growth potential.


Similar Companies

Share Price & News

How has Ryman Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

RHCG.F

-0.04%

US Healthcare

-0.6%

US Market


1 Year Return

n/a

RHCG.F

-9.1%

US Healthcare

0.7%

US Market

No trading data on RHCG.F.

No trading data on RHCG.F.


Share holder returns

RHCG.FIndustryMarket
7 Day0%-0.04%-0.6%
30 Dayn/a1.0%2.9%
90 Dayn/a-1.5%1.3%
1 Yearn/a-7.7%-9.1%2.9%0.7%
3 Year21.7%21.7%29.6%24.3%44.6%35.2%
5 Yearn/a66.1%56.2%61.9%44.2%

Price Volatility Vs. Market

How volatile is Ryman Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Ryman Healthcare undervalued based on future cash flows and its price relative to the stock market?

20.37x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Ryman Healthcare's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Ryman Healthcare's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Ryman Healthcare is good value based on earnings compared to the US Healthcare industry average.

Ryman Healthcare is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Ryman Healthcare is poor value based on expected growth next year.


Price Based on Value of Assets

Ryman Healthcare is overvalued based on assets compared to the US Healthcare industry average.


Next Steps

Future Growth

How is Ryman Healthcare expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

14.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Ryman Healthcare's revenue is expected to grow by 11.2% yearly, however this is not considered high growth (20% yearly).

Ryman Healthcare's earnings are expected to grow by 14.7% yearly, however this is not considered high growth (20% yearly).

Ryman Healthcare's revenue growth is expected to exceed the United States of America market average.

Ryman Healthcare's earnings growth is expected to exceed the United States of America market average.

Ryman Healthcare's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Ryman Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has Ryman Healthcare performed over the past 5 years?

11.4%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Ryman Healthcare's year on year earnings growth rate has been positive over the past 5 years.

Ryman Healthcare's 1-year earnings growth is negative, it can't be compared to the 5-year average.

Ryman Healthcare's 1-year earnings growth is negative, it can't be compared to the US Healthcare industry average.


Return on Equity

Ryman Healthcare has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Ryman Healthcare used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.


Return on Capital Employed

Ryman Healthcare's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Ryman Healthcare's financial position?


Financial Position Analysis

Ryman Healthcare's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Ryman Healthcare's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

Ryman Healthcare's level of debt (61.6%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (30.2% vs 61.6% today).

Debt is well covered by operating cash flow (30%, greater than 20% of total debt).

Interest payments on debt are not well covered by earnings (EBIT is 3x annual interest expense, ideally 3x coverage).


Balance Sheet

Low level of unsold assets.

Debt is not covered by short term assets, assets are 0.3x debt.


Next Steps

Dividend

What is Ryman Healthcare's current dividend yield, its reliability and sustainability?

2.28%

Expected Dividend Yield


Dividend Yield and Payments Analysis

Ryman Healthcare's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.44%).

Ryman Healthcare's dividend is below the markets top 25% of dividend payers in United States of America (3.71%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (2.9x coverage).


Future Payout to Shareholders

Dividends after 3 years are expected to be covered by earnings (2x coverage).


Next Steps

Management

What is the CEO of Ryman Healthcare's salary, the management and board of directors tenure and is there insider trading?

2.3yrs

Average management tenure


CEO

Gordon MacLeod 0

2.2yrs

Tenure

NZ$1,228,753

Compensation

Mr. Gordon MacLeod has been the Chief Executive Officer since July 1, 2017 of Ryman Healthcare Limited since October 26, 2006 and serves as its Secretary and served as its Deputy Chief Executive and Chief  ...


CEO Compensation Analysis

Gordon's remuneration is lower than average for companies of similar size in United States of America.

Gordon's compensation has increased by more than 20% in the past year whilst earnings fell less than 20%.


Management Age and Tenure

2.3yrs

Average Tenure

The tenure for the Ryman Healthcare management team is about average.


Board Age and Tenure

5.8yrs

Average Tenure

The tenure for the Ryman Healthcare board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Tom Brownrigg

    Chief Construction Officer

    • Tenure: 0yrs
  • Gordon MacLeod

    CEO & Secretary

    • Tenure: 2.2yrs
    • Compensation: NZ$1.23m
  • Debbie Versey McClure

    Chief Sales & Marketing Officer

    • Tenure: 2.8yrs
  • Nicole Forster

    Chief People & Technology Officer

    • Tenure: 0yrs
  • David Bennett

    Chief Financial Officer

    • Tenure: 2.3yrs

Board Members

  • David Kerr

    Chairman of the Board

    • Tenure: 20.7yrs
    • Compensation: NZ$217.00k
  • Simon Challies

    Advisor to the Board

    • Tenure: 2.3yrs
    • Compensation: NZ$2.73m
  • George Savvides

    Non-Executive Director

    • Tenure: 6.7yrs
    • Compensation: NZ$136.01k
  • Warren Bell

    Director

    • Tenure: 8.6yrs
    • Compensation: NZ$125.50k
  • Jo Appleyard

    Non-Executive Director

    • Tenure: 10.7yrs
    • Compensation: NZ$108.00k
  • Claire Higgins

    Non-Executive Director

    • Tenure: 5yrs
    • Compensation: NZ$136.01k
  • Anthony Leighs (48yo)

    Independent Director

    • Tenure: 0.9yrs
    • Compensation: NZ$62.75k
  • Geoff Cumming

    Director

    • Tenure: 1.3yrs
    • Compensation: NZ$90.83k

Company Information

Ryman Healthcare Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Ryman Healthcare Limited
  • Ticker: RHCG.F
  • Exchange: OTCPK
  • Founded: 1984
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: NZ$6.536b
  • Listing Market Cap: NZ$4.092b
  • Shares outstanding: 497.42m
  • Website: https://www.rymanhealthcare.co.nz

Number of Employees


Location

  • Ryman Healthcare Limited
  • Airport Business Park
  • 92 Russley Road
  • Christchurch
  • 8042
  • New Zealand

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RYMNZSE (New Zealand Stock Exchange)YesOrdinary SharesNZNZDJun 1999
RHCG.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDJun 1999
RH7DB (Deutsche Boerse AG)YesOrdinary SharesDEEURJun 1999
RYHT.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDNov 2011

Biography

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. Its villages offer a range of retirement living ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/22 00:16
End of Day Share Price2019/08/27 00:00
Earnings2019/03/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.